These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27493357)

  • 21. Chemical Pleurodesis with Oxytetracycline in Congenital Chylothorax.
    Utture A; Kodur V; Mondkar J
    Indian Pediatr; 2016 Dec; 53(12):1105-1106. PubMed ID: 28064267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Congenital chylothorax: associations and neonatal outcomes.
    Downie L; Sasi A; Malhotra A
    J Paediatr Child Health; 2014 Mar; 50(3):234-8. PubMed ID: 24372911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prenatal diagnosis of chylothorax].
    Dendale J; Comet P; Amram D; Lesbros D
    Arch Pediatr; 1999 Aug; 6(8):867-71. PubMed ID: 10472400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of congenital chylothorax with octreotide in a hydropic preterm infant.
    Choo YM; Lim CT
    Paediatr Int Child Health; 2013 May; 33(2):116-9. PubMed ID: 23925288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spontaneous neonatal chylothorax treated with octreotide.
    Siu SL; Lam DS
    J Paediatr Child Health; 2006; 42(1-2):65-7. PubMed ID: 16487393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Congenital chylothorax presenting as hydrops fetalis. A case report.
    Sacks LM; Polin JI; Breckenridge J
    J Reprod Med; 1983 May; 28(5):341-4. PubMed ID: 6152989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with OK-432 for persistent congenital chylothorax in newborn infants resistant to octreotide.
    Matsukuma E; Aoki Y; Sakai M; Kawamoto N; Watanabe H; Iwagaki S; Takahashi Y; Kawabata I; Kondo N; Uchida Y
    J Pediatr Surg; 2009 Mar; 44(3):e37-9. PubMed ID: 19302843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management and outcomes of congenital chylothorax in the neonatal intensive care unit: A case series.
    Healy H; Gipson K; Hay S; Bates S; Kinane TB
    Pediatr Investig; 2017 Dec; 1(1):21-25. PubMed ID: 32851213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Octreotide in the treatment of congenital chylothorax.
    Rasiah SV; Oei J; Lui K
    J Paediatr Child Health; 2004; 40(9-10):585-8. PubMed ID: 15367160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Congenital chylothorax in newborn with trisomy 21.
    Lomauri Kh
    Georgian Med News; 2014 Nov; (236):74-7. PubMed ID: 25541830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Congenital pulmonary lymphangiectasia: an unusual presentation of nonimmune hydrops in a preterm infant.
    Mele P; Sridhar S
    Adv Neonatal Care; 2012 Jun; 12(3):166-71. PubMed ID: 22668688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimodal imaging in the congenital pulmonary lymphangiectasia-congenital chylothorax-hydrops fetalis continuum.
    Bellini C; Mazzella M; Campisi C; Taddei G; Mosca F; Tomà P; Villa G; Boccardo F; Sementa AR; Hennekam RC; Serra G
    Lymphology; 2004 Mar; 37(1):22-30. PubMed ID: 15109074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low Dose of Octreotide Can be Helpful in the Management of Congenital Chylothorax.
    Afsharpaiman S; Rezaee Zavareh MS; Torkaman M
    Iran Red Crescent Med J; 2015 Oct; 17(10):e18915. PubMed ID: 26568847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Congenital chylothorax: rapid and complete response to polyvidone iodine].
    Hmami F; Oulmaati A; Bouchikhi C; Banani A; Bouharrou A
    Arch Pediatr; 2014 Sep; 21(9):1002-5. PubMed ID: 25153807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal Therapy Improves the Survival of Premature Infants with Congenital Chylothorax.
    Lee CJ; Tsao PN; Chen CY; Hsieh WS; Liou JY; Chou HC
    Pediatr Neonatol; 2016 Apr; 57(2):127-32. PubMed ID: 26315047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of octreotide, a long-acting somatostatin analogue, in the treatment of chylothorax of idiopathic etiology.
    Chen-Scarabelli C; Amà R; Abboud J; Jabarren M; Saravolatz L; Scarabelli TM
    Minerva Chir; 2006 Apr; 61(2):155-8. PubMed ID: 16871146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Octreotide, a somatostatin analogue, in the treatment of chylothorax associated with idiopathic fibrosing mediastinitis.
    Togashi Y; Kim YH; Miyahara R; Irisa K; Sakamori Y; Masago K; Mio T; Date H; Mishima M
    Tohoku J Exp Med; 2010 Sep; 222(1):51-3. PubMed ID: 20814178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Non-immunologic hydrops fetalis and congenital chylothorax].
    Dubos JP; Bouchez MC; Kacet N; Rouland V; Morisot C; Bourgeot P
    Arch Fr Pediatr; 1985; 42(7):537-8. PubMed ID: 3841272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thoracoamniotic shunting for fetal pleural effusions with hydrops.
    Picone O; Benachi A; Mandelbrot L; Ruano R; Dumez Y; Dommergues M
    Am J Obstet Gynecol; 2004 Dec; 191(6):2047-50. PubMed ID: 15592290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Influence of prolonged treatment with octreotide on GH, IGF I, insulin, ACTH, cortisol, T3, T4 and TSH secretion in a case of congenital chylothorax].
    Bagnoli F; Badii S; Conte ML; Toti MS; De Felice C; Bellieni CV; Borlini G; Tomasini B; Zani S
    Minerva Pediatr; 2010 Aug; 62(4):411-7. PubMed ID: 20940674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.